Neurodevelopmental Disorders

24 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Broader: Mental Disorders

Narrower: Asperger Syndrome 1, Attention Deficit Disorder with Hyperactivity 8, Autism Spectrum Disorder 14, Autistic Disorder 5, Schizophrenia, Childhood 1

Treatments and conditions

Neurodevelopmental Disorders
Treatment and conditionWhere it standsTrials
Academic Competency Enhancement (ACE) classroom for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Arbaclofen for autism spectrum disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bexicaserin for neurodevelopmental disordersPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Deep Brain Stimulation for autistic disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
EB-1020 (Centanafadine) high dose for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
EB-1020 (Centanafadine) low dose for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Esomeprazole for autistic disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplant (FMT) for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbiota Transplant (FMT) + Vancomycin + NITAZOXANIDE for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
hUC-MSC-Exos Nasal Spray for autism spectrum disorderPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
KarX-EC + KarXT for autism spectrum disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
KarX-EC + KarXT for autistic disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
KarXT for autistic disorderPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Leucovorin for asperger syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Leucovorin for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)5
Leucovorin for autistic disorderTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Levoleucovorin calcium for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Lysergide d-tartrate for attention deficit disorder with hyperactivityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Navigate for schizophrenia, childhoodTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Oxytocin for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Saccharomyces cerevisiae for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
TTYP01 Tablets (12mg or 18mg) for autism spectrum disorderPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vancomycin + NITAZOXANIDE for attention deficit disorder with hyperactivityTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Viloxazine hydrochloride for attention deficit disorder with hyperactivityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.